Respiratory

A recent study examining real-world COPD treatment outcomes has highlighted safety concerns regarding single-inhaler triple therapy compared to the long-acting beta2-agonist (LABA) and inhaled corticosteroid (ICS) combination, particularly in terms of cardiovascular risks.

New research highlights the critical role Aspergillus species play in bronchiectasis, a chronic lung condition marked by airway damage.

Pulmonary hypertension (PH), a life-threatening condition, is commonly seen in patients with interstitial lung disease (ILD), significantly increasing their risk of morbidity and mortality.

Emerging data highlights a critical complication for patients with metastatic lung cancer undergoing treatment with immune checkpoint inhibitors (ICIs), including PD-1 and PD-L1 blockers.

Benralizumab, a monoclonal antibody targeting eosinophilic inflammation, outperformed prednisolone alone in treating acute exacerbations of asthma and COPD in a new study.

Chronic exposure to cigarette smoke (CS) may significantly worsen the severity of influenza A virus (IAV) infections, not only through direct lung damage but also via changes in the microbiota.

Impaired insulin secretion in cystic fibrosis-related diabetes (CFRD) is driven by reduced expression of the GLP-1 receptor (GLP-1R) in pancreatic islet cells, according to the results of a new study.

Obstructive sleep apnea (OSA) severity may hold the key to predicting postoperative cardiorespiratory complications, according to a new study involving over 6,700 patients.